Tirzepatide represents a dual agonist, activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which may explain its particularly robust weight loss effects
This concentration is the standard formulation for multi-dose research-grade reconstitution solutions
- (Naturally Occurring Acetylated and Amidated Form of BPC-157)
Int J Lab Hematol 29:163171 Feng R, Mayuranathan T, Huang P, Doerfler PA, Li Y, Yao Y, Zhang J, Palmer LE, Mayberry K, Christakopoulos GE, Xu P, Li C, Cheng Y, Blobel GA, Simon MC, Weiss MJ (2022) Activation of -globin expression by hypoxia-inducible factor 1
Chemical Structure 2D molecular structure (Source: PubChem) Technical Specifications The peptide contains a disulfide bridge between cysteine residues at positions 7 and 14, contributing to structural stability